Skip to main content
Equibles

Invesco Ltd.

Position in EDIT — Editas Medicine, Inc.

CIK 914208 Atlanta, GA
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$686,489
+$349,430 QoQ
Shares Held
211,880
+55.3% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. EDIT ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $686,489 211,880
2026-03-31 $337,059 136,462
2025-12-31 $112,521 54,889
2025-09-30 $207,216 59,717
2025-06-30 $159,046 72,294
2025-03-31 $100,805 86,902
2024-12-31 $127,207 100,164
2024-09-30 $312,750 91,716
2024-06-30 $408,404 87,453
2024-03-31 $645,249 86,961
2023-12-31 $916,287 90,453
2023-09-30 $644,802 82,667
2023-06-30 $659,929 80,186
2023-03-31 $571,487 78,826
2022-12-31 $494,722 55,775
2022-09-30 $685,463 56,002
2022-06-30 $683,678 57,792
2022-03-31 $1,068,942 56,201
2021-12-31 $942,232 35,489
2021-09-30 $1,575,664 38,356
2021-06-30 $1,898,457 33,518
2021-03-31 $918,834 21,877
2020-12-31 $2,790,167 39,797
2020-09-30 $354,706 12,641
2020-06-30 $378,090 12,782
2020-03-31 $274,823 13,859